Exhibit 99.1

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Q4 total revenues of $138.3 million, up 17% year-over-year

Q4 operating cash flow of $98.5 million, up 54% year-over-year

Q4 free cash flow of $97.0 million, up 56% year-over-year

Fiscal year 2025 total revenues of $570.4 million, up 20% year-over-year

Fiscal year 2025 operating cash flow of $273.3 million, up 48% year-over-year

Fiscal year 2025 free cash flow of $266.7 million, up 50% year-over-year

Fiscal 2025 Fourth Quarter Financial Highlights

Fiscal Year 2025 Financial Highlights

Financial Outlook

Conference Call Information

About Doximity

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors”in the Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Additional information will be provided in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Media Contact:

DOXIMITY, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

			March 31, 2025						March 31, 2024
Assets
Current assets:
Cash and cash equivalents			$	209,614					$	96,785
Marketable securities			706,050						666,115
Accounts receivable, net			128,354						101,332
Prepaid expenses and other current assets			44,602						48,709
Total current assets			1,088,620						912,941
Property and equipment, net			13,656						12,318
Deferred income tax assets			60,014						45,068
Operating lease right-of-use assets			8,886						12,332
Intangible assets, net			23,072						27,317
Goodwill			67,940						67,940
Other assets			2,121						1,458
Total assets			$	1,264,309					$	1,079,374
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable			$	1,356					$	2,253
Accrued expenses and other current liabilities			38,405						43,703
Deferred revenue, current			114,285						99,145
Operating lease liabilities, current			2,211						2,149
Total current liabilities			156,257						147,250
Deferred revenue, non-current			280						211
Operating lease liabilities, non-current			10,185						12,397
Contingent earn-out consideration liability, non-current			5,579						10,895
Other liabilities, non-current			9,383						7,224
Total liabilities			181,684						177,977
Stockholders' Equity
Preferred stock			—						—
Common stock			189						187
Additional paid-in capital			894,225						823,885
Accumulated other comprehensive income (loss)			1,323						(2,664)
Retained earnings			186,888						79,989
Total stockholders' equity			1,082,625						901,397
Total liabilities and stockholders’ equity			$	1,264,309					$	1,079,374

DOXIMITY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

DOXIMITY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

			Three Months Ended March 31,												Fiscal Year Ended March 31,
			2025						2024						2025						2024
Cash flows from operating activities
Net income			$	62,458					$	40,618					$	223,185					$	147,582
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			2,829						2,548						10,659						10,265
Deferred income taxes			(13,788)						(8,593)						(11,592)						(8,593)
Stock-based compensation, net of amounts capitalized			18,060						11,857						72,386						51,076
Non-cash lease expense			446						475						1,838						2,074
Accretion of discount on marketable securities, net			(2,919)						(1,761)						(11,655)						(5,238)
Amortization of deferred contract costs			3,423						2,593						9,967						8,871
Impairment of long-lived assets			—						—						2,304						—
Other			(19)						956						270						2,583
Changes in operating assets and liabilities:
Accounts receivable			9,258						(4,516)						(27,206)						3,993
Prepaid expenses and other assets			(18,489)						(16,502)						2,762						(20,483)
Deferred contract costs			(2,982)						(1,683)						(12,051)						(8,608)
Accounts payable, accrued expenses and other liabilities			(4,535)						5,966						(663)						8,332
Deferred revenue			45,295						32,496						15,210						(6,080)
Operating lease liabilities			(550)						(510)						(2,149)						(1,678)
Net cash provided by operating activities			98,487						63,944						273,265						184,096
Cash flows from investing activities
Purchases of property and equipment			—						—						—						(147)
Internal-use software development costs			(1,507)						(1,634)						(6,525)						(5,654)
Purchases of marketable securities			(143,724)						(191,529)						(675,557)						(472,867)
Maturities of marketable securities			118,180						116,993						635,401						435,179
Sales of marketable securities			2,578						—						17,383						74,675
Net cash provided by (used in) investing activities			(24,473)						(76,170)						(29,298)						31,186
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants			5,827						3,134						19,732						12,892
Proceeds from issuance of common stock in connection with the employee stock purchase plan			2,147						1,952						3,569						3,446
Taxes paid related to net share settlement of equity awards			(10,856)						(1,424)						(27,185)						(6,756)
Repurchase of common stock			(26,788)						(17,740)						(120,293)						(280,716)
Payment of contingent consideration related to a business combination			—						—						(5,470)						(5,390)
Payment of excise taxes on share repurchases			—						—						(1,491)						—
Net cash used in financing activities			(29,670)						(14,078)						(131,138)						(276,524)
Net increase (decrease) in cash and cash equivalents			44,344						(26,304)						112,829						(61,242)
Cash and cash equivalents, beginning of period			165,270						123,089						96,785						158,027
Cash and cash equivalents, end of period			$	209,614					$	96,785					$	209,614					$	96,785
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds			$	19,840					$	12,911					$	55,654					$	51,274

Non-GAAP Financial Measures

Key Business Metrics

Reconciliation of GAAP to Non-GAAP Financial Measures